SCHEMBL23754201

SCHEMBL23754201

CC(=O)OC1(c2ccnc(Cl)n2)CC=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21410495 0.69 — —
SCHEMBL21373841 0.66 TRPV1 (0.36) —
SCHEMBL21381411 0.65 AKR1C1 (0.34) —
SCHEMBL21410336 0.64 — —
SCHEMBL21373824 0.64 IDO1 (0.35) —
SCHEMBL23850569 0.64 FLT4 (0.34) —
SCHEMBL22576541 0.63 PARG (0.31) —
SCHEMBL22758534 0.63 IDO1 (0.35) —
SCHEMBL21392115 0.63 — —
SCHEMBL21410338 0.62 AKR1C1 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4103563-A1 HETEROCYCLIC GLP-1 AGONISTS Gasherbrum Bio, Inc. (US) 2022-12-21 — — EP disclosed
WO-2021160127-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2021-08-19 — — WO disclosed
Send feedback